Artificial Intelligence | News | Insights | AiThority
Bitcoin
$11,455.63
-252.04
(-2.15%)
Ethereum
$379.43
-10.57
(-2.71%)
Ripple
$0.28
-0.01
(-4.17%)
Litecoin
$54.36
-3.01
(-5.25%)
EOS
$3.00
-0.12
(-3.84%)
Cardano
$0.13
-0.01
(-5.39%)
Stellar
$0.10
-0
(-4.02%)
NEO
$14.04
-0.17
(-1.2%)
NEM
$0.06
-0
(-1.31%)
DigitalCash
$89.48
-3.93
(-4.21%)
Tether
$1.00
-0
(-0.1%)
Binance Coin
$21.83
-0.15
(-0.68%)
QTUM
$2.69
-0.09
(-3.22%)
Verge
$0.01
0
(+6.56%)
Ontology
$0.75
-0.05
(-6.53%)
ZCash
$82.50
-3.4
(-3.96%)
Steem
$0.22
-0.02
(-6.63%)

Paige Applauded by Frost & Sullivan for Its Leading AI-based Computational Pathology Offering

0 5

Paige leveraged the world’s largest dataset in pathology to develop an unparalleled computation pathology offering

Based on its recent analysis of the North American AI-based digital pathology market, Frost & Sullivan recognizes Paige with the 2020 North American Enabling Technology Leadership Award for its disruptive product offering.

Paige has developed robust machine learning models for computational pathology for detecting cancer subtypes, thereby enhancing the diagnosis capability of pathologists worldwide. Paige’s AI-based technology was developed and tested on over 100,000 de-identified, digitized slide images from more than 16,000 cancer patients. The deep learning algorithms detected prostate cancer, skin cancer, and breast cancer with near-perfect accuracy.

Recommended AI News: Mojodomo Introduces The World’s First Zero-Waste, Performance-Based Solution To Loyalty Marketing

“Paige’s AI algorithms validated against the world’s largest dataset in pathology makes it the most trustworthy best in class pathology diagnosis solution,” said Debarati Sengupta, Industry Analyst, Frost & Sullivan. “Paige’s technology eliminates the need to curate datasets, which is time-consuming and expensive. Paige’s AI based pathology offering enables pathologists to make a fast and accurate diagnosis of even the most complex and difficult to interpret slides.”

The Paige offering consists of general and organ-specific products that provide rapid diagnostic stratification, cancer detection, tumor segmentation, and prediction of treatment response, and overall survival. Its algorithms form a portfolio of AI-based digital diagnostics and biomarkers to help pathologists provide diagnoses. For security purposes, all datasets used to build the products were de-identified, and any protected health information or label text was removed.

Recommended AI News: Cityzenith Unveils New Highly-Advanced Digital Twin Technology – SmartWorldPro2

Notably, Paige’s computational pathology offering received the Breakthrough Device designation by the US Food and Drug Administration (FDA) in 2019, making it the first such device for cancer diagnosis. Furthermore, it began commercializing in 2019 following its CE mark approval for Paige Prostate, which is a first-to-market prostate cancer detection solution, and a digital pathology viewer for the primary diagnosis of any digital slide. Paige’s AI-based solutions are vendor agnostic, which helps it serve a wider pool of customers.

In 2020, it formed a strategic partnership with Invicro LLC, a Konica Minolta company to provide its AI-based integrated pathology solutions to support Invicro’s drug discovery and development initiatives. “Paige continues to expand its footprint not just in commercial laboratories, but also in biopharmaceutical companies, positioning itself as a pioneer in AI-based digital pathology market” noted Sengupta.

Each year, Frost & Sullivan presents this award to a company that has developed a pioneering technology that not only enhances current products but also enables the development of new products and applications. The award recognizes the high market acceptance potential of the recipient’s technology.

Frost & Sullivan Best Practices awards recognize companies in a variety of regional and global markets for demonstrating outstanding achievement and superior performance in areas such as leadership, technological innovation, customer service, and strategic product development. Industry analysts compare market participants and measure performance through in-depth interviews, analysis, and extensive secondary research to identify best practices in the industry.

Recommended AI News: Education Ecosystem Adds New Projects In Response To Increase In Users During Coronavirus Pandemic

Leave A Reply

Your email address will not be published.

This site uses Akismet to reduce spam. Learn how your comment data is processed.